Cargando…
Potentiation of rifampin activity in a mouse model of tuberculosis by activation of host transcription factor EB
Efforts at host-directed therapy of tuberculosis have produced little control of the disease in experimental animals to date. This is not surprising, given that few specific host targets have been validated, and reciprocally, many of the compounds tested potentially impact multiple targets with both...
Autores principales: | Bryk, Ruslana, Mundhra, Shashirekha, Jiang, Xiuju, Wood, Madeleine, Pfau, Daniel, Weber, Elaina, Park, Suna, Zhang, Li, Wilson, Colin, Van der Westhuyzen, Renier, Street, Leslie, Chibale, Kelly, Zimmerman, Matthew, Dartois, Véronique, Pastore, Nunzia, Ballabio, Andrea, Hawryluk, Natalie, Canan, Stacie, Khetani, Vikram, Camardo, Joseph, Nathan, Carl |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7337396/ https://www.ncbi.nlm.nih.gov/pubmed/32574211 http://dx.doi.org/10.1371/journal.ppat.1008567 |
Ejemplares similares
-
Etymologia: Rifampin
por: Henry, Ronnie
Publicado: (2018) -
Transcription factor EB overexpression prevents neurodegeneration in experimental synucleinopathies
por: Arotcarena, Marie-Laure, et al.
Publicado: (2019) -
Transcription factor EB (TFEB) is a new therapeutic target for Pompe disease
por: Spampanato, Carmine, et al.
Publicado: (2013) -
Multiple Mechanisms Converging on Transcription Factor EB Activation by the Natural Phenol Pterostilbene
por: La Spina, Martina, et al.
Publicado: (2021) -
Novel insights into the epidemiology of epidermolysis bullosa (EB) from the Dutch EB Registry: EB more common than previously assumed?
por: Baardman, R., et al.
Publicado: (2020)